
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8713495
[patent_doc_number] => 08399635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Chitosan derivatives to treat animals or optimize animal health'
[patent_app_type] => utility
[patent_app_number] => 12/617349
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13174
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12617349
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617349 | Chitosan derivatives to treat animals or optimize animal health | Nov 11, 2009 | Issued |
Array
(
[id] => 6457405
[patent_doc_number] => 20100105864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIARRHEA'
[patent_app_type] => utility
[patent_app_number] => 12/613727
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11780
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105864.pdf
[firstpage_image] =>[orig_patent_app_number] => 12613727
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/613727 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIARRHEA | Nov 5, 2009 | Abandoned |
Array
(
[id] => 6222717
[patent_doc_number] => 20100056488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'CORTICOSTEROID CONJUGATES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/612273
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8512
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056488.pdf
[firstpage_image] =>[orig_patent_app_number] => 12612273
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/612273 | CORTICOSTEROID CONJUGATES AND USES THEREOF | Nov 3, 2009 | Abandoned |
Array
(
[id] => 6585212
[patent_doc_number] => 20100047849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'DETERMINATION OF TESTOSTERONE BY MASS SPECTROMETRY'
[patent_app_type] => utility
[patent_app_number] => 12/607905
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9748
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12607905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/607905 | Determination of testosterone by mass spectrometry | Oct 27, 2009 | Issued |
Array
(
[id] => 12226623
[patent_doc_number] => 09913850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut'
[patent_app_type] => utility
[patent_app_number] => 13/122241
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5871
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122241
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122241 | Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut | Sep 30, 2009 | Issued |
Array
(
[id] => 6251720
[patent_doc_number] => 20100028300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/567861
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28448
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12567861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/567861 | MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS | Sep 27, 2009 | Abandoned |
Array
(
[id] => 7682061
[patent_doc_number] => 20100022747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'PROPHYLACTIC AGENT FOR HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/567322
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8533
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022747.pdf
[firstpage_image] =>[orig_patent_app_number] => 12567322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/567322 | PROPHYLACTIC AGENT FOR HEART FAILURE | Sep 24, 2009 | Abandoned |
Array
(
[id] => 7682060
[patent_doc_number] => 20100022748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'PROPHYLACTIC AGENT FOR RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/567628
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12567628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/567628 | PROPHYLACTIC AGENT FOR RENAL FAILURE | Sep 24, 2009 | Abandoned |
Array
(
[id] => 6064163
[patent_doc_number] => 20110201555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'NOVEL ESTROGEN RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/998065
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18923
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998065 | NOVEL ESTROGEN RECEPTOR LIGANDS | Sep 17, 2009 | Abandoned |
Array
(
[id] => 8410309
[patent_doc_number] => 08273706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Isobarically labeled analytes and fragment ions derived therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/561074
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 39
[patent_no_of_words] => 41309
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12561074
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561074 | Isobarically labeled analytes and fragment ions derived therefrom | Sep 15, 2009 | Issued |
Array
(
[id] => 6630453
[patent_doc_number] => 20100004339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/559324
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20132
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12559324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/559324 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | Sep 13, 2009 | Abandoned |
Array
(
[id] => 7574014
[patent_doc_number] => 20110269670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'CARBOHYDRATE BINDING MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/063537
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12574
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269670.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063537
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063537 | Carbohydrate binding molecules | Sep 10, 2009 | Issued |
Array
(
[id] => 9354757
[patent_doc_number] => 08673288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Compositions and methods for inhibiting entry of a hepatic virus'
[patent_app_type] => utility
[patent_app_number] => 13/061598
[patent_app_country] => US
[patent_app_date] => 2009-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 9692
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061598 | Compositions and methods for inhibiting entry of a hepatic virus | Aug 31, 2009 | Issued |
Array
(
[id] => 7540550
[patent_doc_number] => 08058393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Microwave-assisted peptide synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/549445
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 8697
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058393.pdf
[firstpage_image] =>[orig_patent_app_number] => 12549445
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/549445 | Microwave-assisted peptide synthesis | Aug 27, 2009 | Issued |
Array
(
[id] => 8797072
[patent_doc_number] => 08435939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Polypeptide anti-HIV agent containing the same'
[patent_app_type] => utility
[patent_app_number] => 12/583746
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10160
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12583746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583746 | Polypeptide anti-HIV agent containing the same | Aug 24, 2009 | Issued |
Array
(
[id] => 6492689
[patent_doc_number] => 20100093628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'METHODS OF TREATMENT USING WISP POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/537888
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 27373
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12537888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537888 | Methods of treatment using WISP polypeptides | Aug 6, 2009 | Issued |
Array
(
[id] => 8189259
[patent_doc_number] => 08183211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Pharmaceutical compositions for inhibiting intestinal permeability'
[patent_app_type] => utility
[patent_app_number] => 12/536158
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6456
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183211.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536158
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536158 | Pharmaceutical compositions for inhibiting intestinal permeability | Aug 4, 2009 | Issued |
Array
(
[id] => 9777951
[patent_doc_number] => 08853156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Treatment for diabetes in patients inappropriate for metformin therapy'
[patent_app_type] => utility
[patent_app_number] => 13/057295
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13092
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057295
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057295 | Treatment for diabetes in patients inappropriate for metformin therapy | Aug 4, 2009 | Issued |
Array
(
[id] => 6639695
[patent_doc_number] => 20100036092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Synthesis of Glatiramer Acetate'
[patent_app_type] => utility
[patent_app_number] => 12/536023
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2236
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20100036092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536023 | Synthesis of glatiramer acetate | Aug 4, 2009 | Issued |
Array
(
[id] => 6625607
[patent_doc_number] => 20100172834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'METHOD FOR AUTOMATED, LARGE-SCALE MEASUREMENT OF THE MOLECULAR FLUX RATES OF THE PROTEOME OR THE ORGANEOME USING MASS SPECTROMETRY'
[patent_app_type] => utility
[patent_app_number] => 12/534807
[patent_app_country] => US
[patent_app_date] => 2009-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11027
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12534807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/534807 | Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry | Aug 2, 2009 | Issued |